Collection of genomic samples for childhood genetic diseases

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Rady Children's Institute for Genomic Medicine is establishing a biorepository to collect biological samples and genomic sequences from children with genetic diseases. This resource will facilitate future research aimed at understanding the genomic causes and treatments for childhood diseases. The biorepository will also enable immediate analysis of genomic data to assist in diagnosing genetic conditions, with results integrated into patients' electronic health records. By including a diverse population, the initiative aims to enhance the understanding of genetic diseases across various ethnic and racial groups.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All ages, races, genders, ethnicities, and health status will be eligible for participation. Enrollment will include that following vulnerable populations: pregnant women, neonates, fetuses, those with cognitive disabilities, pediatric patients, minorities, and employees.

Exclusion Criteria:

* None

Where it's running

• Rady Pediatric Genomics & Systems Medicine Institute
  San Diego, California, United States Recruiting

Study contacts

• Principal investigator: Stephen Kingsmore, MD, MSc — Rady Pediatric Genomics & Systems Medicine Institute
• Study coordinator: Dominic Baun, MBS
• Email: jbaun@rchsd.org
• Phone: 858-576-1700

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• HSCT outcomes in children at Ramathibodi Hospital

  This study tests how hematopoietic stem cell transplantation works in pediatric patients with blood diseases, cancers, and other conditions at Ramathibodi Hospital.

  Recruiting Mahidol University · Ratchathewi, Bangkok · NCT07857746

• AOC 1044 in Duchenne Muscular Dystrophy with Exon 44 Skipping

  This study tests whether intravenous AOC 1044 helps boys with Duchenne muscular dystrophy caused by mutations amenable to exon 44 skipping.

  Recruiting at 20 sites Phase 3 Avidity Biosciences, Inc. · Westmead, New South Wales and 19 other locations · NCT07587242

• Long-term monitoring of adults with type I interferon autoantibodies or genetic interferon defects

  We will follow adults who have autoantibodies to type I interferons or genetic defects that impair interferon responses to see if they develop more infections or autoimmune problems and how antibody levels change over time.

  Recruiting at 9 sites Institut National de la Santé Et de la Recherche Médicale, France · Lille and 8 other locations · NCT06762002

• Natural history of PKP2-related arrhythmogenic cardiomyopathy

  This project will collect past and ongoing health information to see how PKP2-related arrhythmogenic cardiomyopathy progresses in people managed with standard care.

  Recruiting at 2 sites Rocket Pharmaceuticals Inc. · Boston, Massachusetts and 2 other locations · NCT06644742

• Characterizing genetic diseases affecting the immune and neurological systems

  This study is trying to learn more about rare genetic diseases that affect the immune and nervous systems to help find better ways to diagnose and treat them.

  Recruiting Imagine Institute · Paris, Île-de-France Region · NCT06235580

• Identifying genetic and metabolic diseases in children

  This study is trying to find new genetic causes of rare diseases in children by looking closely at their genes and metabolism.

  Recruiting University of Texas Southwestern Medical Center · Dallas, Texas · NCT02650622

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.